Zambon Spa
Clinical trials sponsored by Zambon Spa, explained in plain language.
-
Inhaled drug shows promise for lung transplant rejection in small trial
Disease control CompletedThis study tested an inhaled form of cyclosporine A (a drug that calms the immune system) added to standard care for people who had a single lung transplant and developed chronic rejection (bronchiolitis obliterans). The goal was to see if it could slow the decline in lung functi…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Inhaled drug shows promise for lung transplant rejection in phase 3 trial
Disease control CompletedThis study tested whether adding an inhaled form of cyclosporine A (L-CsA) to standard treatment helps people who have chronic lung rejection after a double lung transplant. The trial included 169 adults who had their transplant at least a year earlier. The main goal was to see i…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Can a common antioxidant help you cough up phlegm easier?
Symptom relief CompletedThis study tested whether a one-week course of intravenous N-acetylcysteine (NAC) helps adults with respiratory diseases cough up thick mucus more easily. 333 hospitalized patients in China received either NAC, another drug (ambroxol), or a placebo. The results showed NAC was bet…
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC